Biopreservation Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Biopreservation Market is Segmented by Product (Biopreservation Media and Equipment), Application Area (Biobanking, Regenerative Medicine, Drug Discovery, and Other Application Areas), End User (Biobanks, Hospitals, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle-East and Africa, and South America).

Market Snapshot

Biopreservation Market CAGR
Study Period:

2018 - 2026

Base Year:

2020

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

15.3 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

  • The biopreservation market is expected to witness a CAGR of 15.3% during the forecast period. Certain factors driving the market growth include improving healthcare expenditure, adoption of in-house sample storage in hospitals and labs, and increasing R&D investment.
  • Healthcare expenditure continues to increase faster than economic growth in most countries, maintaining a trend observed over the decades. The presence of equitable, responsive, and efficient health systems across North America, Europe, and Asia Pacific has also contributed to the maximum possible share of GDP being utilized for healthcare expenditure. Biopreservation has broad public health and socio-economic impacts, and it is affecting many lives across the world. It has been widely used to preserve cells and tissues, targeting its reproductive medicine and organ transplantation applications. Stem cell banking and gene banking have also gained global popularity. 
  • With the growing healthcare expenditure each year, the government collaborations with companies and universities for better exposure to the technology used and its development for higher efficiency are increasing. With growing technological advancements in biopreservation and healthcare equipment, along with the cost-effectiveness of these instruments, a major share of healthcare spending is going to be invested in this domain.
  • However, concerns with the transition from laboratory to the market include the major problems of preservation and storage of tissues or cells. Despite the protection, the processes of freezing and thawing often cause tissue damage or cell injury. This factor hinders the growth of the market potential of biopreservation. Tissue cryopreservation is highly complicated and difficult than cryopreservation of individual cells. Injuries to cells during freezing and thawing are related to the physicochemical and biophysical changes that occur during cryopreservation.

Scope of the Report

Biopreservation is a process that helps store biological samples for a longer period. Cells, tissues, and plasmas are some of the common biological samples preserved through biopreservation.

By Products
Biopreservation Media
Equipment
Temperature Maintaining Units
Consumables
Other Equipment
By Application Area
Biobanking
Regenerative Medicine
Drug Discovery
Other Application Areas
By End User
Biobanks
Hospitals
Other End Users
By Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Biopreservation Media is Expected to Hold Significant Market Share in the Product Type Segment

Nutrient media has found wide application in stem cell therapy and transplanted organ preservation. Tissue engineering, which includes stem cell storage, has seen prominent usage of nutrient media. Early-stage of stem cell culture depends on a continuous supply of oxygen and nutrition diffusion. Stem cell engineering has been widely used for treating bone defects. 

Nutrient media has also been used exclusively for organ preservation and organ transportation. The most common approaches for organ preservation during an organ transplant are simple static cold storage (SCS) and hypothermic machine perfusion (HMP). They are approved for transplantation of the liver, lungs, pancreas, heart, and kidney.

Biopreservation Market

To understand key trends, Download Sample Report

North America Dominates the Market and Expected to do Same in the Forecast Period

The North American market is primarily driven by the rise in demand for preservation of blood, solid tissue specimen, including paraffin-embedded or frozen bio-specimen of tumors, and other tissues (like peripheral blood cells, bone marrow, and stem cells-derived cord blood and its derivatives), across multiple research institutes, pathological centers, and hospitals. Favorable government regulations have also been observed in this region, which is supporting the sharing of biological samples.

Biopreservation Market

To understand geography trends, Download Sample Report

Competitive Landscape

The biopreservation market is highly competitive and consists of several major players. Companies, like BioCision LLC, BioLife Solutions Inc., Cesca Therapeutics Inc., Core Dynamics Ltd, Custom Biogenic Systems Inc., Lifeline Scientific Inc., Merck KGaA, Princeton CryoTech Inc., and VWR International, hold a substantial market share in the market studied.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Improving Healthcare Expenditure

      2. 4.2.2 Adoption of In-house Sample Storage in Hospitals and Labs

      3. 4.2.3 Increasing R&D Investment

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of the Instruments and its Maintenance

      2. 4.3.2 Possibility of Tissue Injury During Preservation and Thawing

    4. 4.4 Industry Attractiveness - Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Products

      1. 5.1.1 Biopreservation Media

      2. 5.1.2 Equipment

        1. 5.1.2.1 Temperature Maintaining Units

        2. 5.1.2.2 Consumables

        3. 5.1.2.3 Other Equipment

    2. 5.2 By Application Area

      1. 5.2.1 Biobanking

      2. 5.2.2 Regenerative Medicine

      3. 5.2.3 Drug Discovery

      4. 5.2.4 Other Application Areas

    3. 5.3 By End User

      1. 5.3.1 Biobanks

      2. 5.3.2 Hospitals

      3. 5.3.3 Other End Users

    4. 5.4 By Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 BioCision LLC

      2. 6.1.2 BioLife Solutions Inc.

      3. 6.1.3 Cesca Therapeutics Inc.

      4. 6.1.4 Core Dynamics Ltd

      5. 6.1.5 Custom Biogenic Systems Inc.

      6. 6.1.6 Lifeline Scientific Inc.

      7. 6.1.7 Merck KGaA

      8. 6.1.8 Princeton CryoTech Inc.

      9. 6.1.9 VWR International

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Biopreservation Market market is studied from 2018 - 2026.

The Biopreservation Market is growing at a CAGR of 15.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

  • BioLife Solutions Inc.
  • Lifeline Scientific Inc.
  • Merck KGaA
  • Princeton CryoTech Inc.
  • BioCision LLC

Are the major companies operating in Biopreservation Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!